These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Clinical experiences with triethylene melamine in therapy of neoplastic diseases of the blood]. BOCK HE; KIRBERGER E; WOELFFER U Z Klin Med; 1953; 150(5):482-98. PubMed ID: 13137291 [No Abstract] [Full Text] [Related]
4. [Triethylene melamine therapy of leukemia and lymphogranulomatosis]. MILIC N Lijec Vjesn; 1954; 76(1-2):40-6. PubMed ID: 13175578 [No Abstract] [Full Text] [Related]
5. Results in the use of triethylene melamine (TEM) in malignant lymphomas and chronic leukemias. MEZA ARRAU C; NIJAMKIN A Rev Med Chil; 1955 Feb; 83(2):90-5. PubMed ID: 14385308 [No Abstract] [Full Text] [Related]
6. [Triethylene melamine treatment of leukemia and lymphogranulomatosis]. CAKMAKCI A Turk Tip Cemiy Mecm; 1954 Jun; 20(6):290-314. PubMed ID: 13217043 [No Abstract] [Full Text] [Related]
7. [Immediate results of triethylene melamine therapy of neoplastic diseases]. LENTI G; GAVOSTO F Minerva Med; 1953 Jan; 44(1-2):1-19. PubMed ID: 13054386 [No Abstract] [Full Text] [Related]
8. Treatment of lymphomatous diseases with triethylene melamine. MEYER LM; SCHWARTZ SO; SAWITSKY A; BEYERS MR; RITZ ND; BRAHIN C; DIEFENBACH W; KLEINSCHMIDT W; FRIEDMAN I Acta Med Scand Suppl; 1952; 272():1-36. PubMed ID: 13039963 [No Abstract] [Full Text] [Related]
9. [Triethylene melamine therapy of malignant granulomatosis and certain other malignant diseases]. HANSEN PB; BICHEL J Nord Med; 1952 Jan; 47(2):58-61. PubMed ID: 14910945 [No Abstract] [Full Text] [Related]
10. [Treatment of hemoblastosis with triethylene melamine]. LINKE A; LASCH HG Dtsch Med Wochenschr; 1953 Jun; 78(25):911-6. PubMed ID: 13068032 [No Abstract] [Full Text] [Related]
11. [Cytostasis due to triethylene melamine (TEM) in lymphogranulomatosis and chronic leukemia]. NEUMANN C Klin Wochenschr; 1952 Dec; 30(47-48):1105-8. PubMed ID: 13023980 [No Abstract] [Full Text] [Related]
12. [Effect of TEM on chronic leukemia, lymphogranulomatosis and lymphosarcoma]. HAEHNER E; HEINEN W; LOOSEN H; SCHMIDT H Med Klin; 1954 May; 49(21):853-4; passim. PubMed ID: 13164965 [No Abstract] [Full Text] [Related]
13. [Clinical trials with triethylene melamine]. FERRARI M; KASDORF H Arch Urug Med Cir Espec; 1953; 42(3-4):134-44. PubMed ID: 14350952 [No Abstract] [Full Text] [Related]
14. Triethylene melamine in human malignant disease; results with oral administration of enteric-coated tablets. PATERSON E; KUNKLER PB; WALPOLE AL Br Med J; 1953 Jan; 1(4801):59-64. PubMed ID: 12997844 [No Abstract] [Full Text] [Related]
16. Triethylene melamine (TEM) in the treatment of malignant lymphoid disease. HAMBLY CK; ROBERTSON TI Med J Aust; 1955 Jun; 42(1 25):900-11. PubMed ID: 13243982 [No Abstract] [Full Text] [Related]
17. Triethylene melamine therapy in Hodgkin's and other malignant diseases. HANSEN PB; BICHEL J Acta Radiol (Stockh); 1951 Dec; 36(6):469-76. PubMed ID: 14902588 [No Abstract] [Full Text] [Related]
18. Triethylene melamine in the treatment of neoplastic disease. RUNDLES RW; BARTON WB Blood; 1952 May; 7(5):483-507. PubMed ID: 14925143 [No Abstract] [Full Text] [Related]
19. [Treatment of Hodgkin's disease with triethylene melamine; preliminary report]. BOLIO MONSREAL E Bol Liga Contra Cancer Havana; 1953 Jun; 28(3):56-62. PubMed ID: 13115509 [No Abstract] [Full Text] [Related]
20. [Effects of x-ray and triethylene melamine in a case of lymphogranulomatosis]. VOSS C Dtsch Med J; 1955 Feb; 6(3-4):103-5. PubMed ID: 14365476 [No Abstract] [Full Text] [Related] [Next] [New Search]